Showing results (2431-2440 of 3,449) with videos related to

Sort By:
Pageof 345
Respirology (Carlton, Vic.)|March 15, 2019
The past, present and future of pulmonary rehabilitationThierry Troosters, Astrid Blondeel, Wim Janssens, et al.
Respirology (Carlton, Vic.)|February 20, 2019
Paediatric and adult bronchiectasis: Diagnosis, disease burden and prognosisJennifer K Quint, Maeve P Smith
Respirology (Carlton, Vic.)|February 16, 2017
AGER gene polymorphisms and soluble receptor for advanced glycation end product in patients with idiopathic pulmonary fibrosisKakuhiro Yamaguchi, Hiroshi Iwamoto, Yasushi Horimasu, et al.
Respirology (Carlton, Vic.)|April 22, 2017
Induced pluripotent stem cells reduce neutrophil chemotaxis via activating GRK2 in endotoxin-induced acute lung injuryVincent Yi-Fong Su, Shih-Hwa Chiou, Chi-Shiuan Lin, et al.
Respirology (Carlton, Vic.)|April 2, 2019
Nocturnal hypoxaemia is associated with adverse outcomes in interstitial lung diseaseLauren K Troy, Iven H Young, Edmund M T Lau, et al.
Respirology (Carlton, Vic.)|January 20, 2017
Thoracic ultrasound recognition of competence: A position paper of the Thoracic Society of Australia and New ZealandJonathan P Williamson, Scott H Twaddell, Y C Gary Lee, et al.
Respirology (Carlton, Vic.)|January 20, 2017
How is physical activity measured in lung cancer?A systematic review of outcome measures and their psychometric propertiesLara Edbrooke, Linda Denehy, Selina M Parry, et al.
Respirology (Carlton, Vic.)|February 22, 2017
High-sensitivity cardiac troponin T predicts mortality after hospitalization for community-acquired pneumoniaStefan M T Vestjens, Simone M C Spoorenberg, Ger T Rijkers, et al.
Respirology (Carlton, Vic.)|February 3, 2017
Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive SummaryClaus F Vogelmeier, Gerard J Criner, Fernando J Martinez, et al.
Respirology (Carlton, Vic.)|March 21, 2017
Pirfenidone and nintedanib for pulmonary fibrosis in clinical practice: Tolerability and adverse drug reactionsJonathan A Galli, Aloknath Pandya, Michelle Vega-Olivo, et al.
Pageof 345